These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 12791302)
1. Long-term, low-level exposure of guinea pigs and marmosets to sarin vapor in air: lowest observable effect level. Van Helden HP; Trap HC; Oostdijk JP; Kuijpers WC; Langenberg JP; Benschop HP Toxicol Appl Pharmacol; 2003 Jun; 189(3):170-9. PubMed ID: 12791302 [TBL] [Abstract][Full Text] [Related]
2. Low-level exposure of guinea pigs and marmosets to sarin vapour in air: lowest-observable-adverse-effect level (LOAEL) for miosis. van Helden HP; Trap HC; Kuijpers WC; Oostdijk JP; Benschop HP; Langenberg JP J Appl Toxicol; 2004; 24(1):59-68. PubMed ID: 14745848 [TBL] [Abstract][Full Text] [Related]
3. Low levels of sarin affect the EEG in marmoset monkeys: a pilot study. van Helden HP; Vanwersch RA; Kuijpers WC; Trap HC; Philippens IH; Benschop HP J Appl Toxicol; 2004; 24(6):475-83. PubMed ID: 15558834 [TBL] [Abstract][Full Text] [Related]
4. Inhalation toxicity of Cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: potency comparison to sarin (GB). Anthony JS; Haley M; Manthei J; Way R; Burnett D; Gaviola B; Sommerville D; Crosier R; Mioduszewski R; Thomson S; Crouse C; Matson K Inhal Toxicol; 2004 Feb; 16(2):103-11. PubMed ID: 15204783 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of sarin (GB) following a single sublethal inhalation exposure in the guinea pig. Whalley CE; McGuire JM; Miller DB; Jakubowski EM; Mioduszewski RJ; Thomson SA; Lumley LA; McDonough JH; Shih TM Inhal Toxicol; 2007 Jun; 19(8):667-81. PubMed ID: 17510839 [TBL] [Abstract][Full Text] [Related]
6. Lung damage following whole body, but not intramuscular, exposure to median lethality dose of sarin: findings in rats and guinea pigs. Chapman S; Lazar S; Gez R; Rabinovitz I; Yaakov G; Grauer E Inhal Toxicol; 2019 Apr; 31(5):203-211. PubMed ID: 31359796 [No Abstract] [Full Text] [Related]
13. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. van der Schans MJ; Lander BJ; van der Wiel H; Langenberg JP; Benschop HP Toxicol Appl Pharmacol; 2003 Aug; 191(1):48-62. PubMed ID: 12915103 [TBL] [Abstract][Full Text] [Related]
14. Protection and inflammatory markers following exposure of guinea pigs to sarin vapour: comparative efficacy of three oximes. Levy A; Chapman S; Cohen G; Raveh L; Rabinovitz I; Manistersky E; Kapon Y; Allon N; Gilat E J Appl Toxicol; 2004; 24(6):501-4. PubMed ID: 15558827 [TBL] [Abstract][Full Text] [Related]
15. Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits. Grauer E; Chapman S; Rabinovitz I; Raveh L; Weissman BA; Kadar T; Allon N Toxicol Appl Pharmacol; 2008 Mar; 227(2):265-74. PubMed ID: 18164360 [TBL] [Abstract][Full Text] [Related]
16. Effects of sarin on the operant behavior of guinea pigs. Langston JL; Adkins AL; Moran AV; Rockwood GA; Deford MS Neurotoxicol Teratol; 2005; 27(6):841-53. PubMed ID: 16046097 [TBL] [Abstract][Full Text] [Related]